In 2023, the number of new and relapse tuberculosis cases in the US stood at 7.45 thousand. Forecasts suggest a steady decline in these cases, dropping to 7.19 thousand in 2024, 6.94 thousand in 2025, and continuing this trend through 2028. Year-on-year, the projected decreases are modest but consistent, highlighting a successful containment strategy. Over the five years, a compound annual growth rate (CAGR) indicates an average annual decrease in cases.
Future trends to watch for include:
- Potential impacts of public health interventions and their sustainability.
- Emergence of drug-resistant tuberculosis strains.
- Socio-economic factors influencing healthcare access and tuberculosis control.
- Technological advancements in diagnosis and treatment.
